Literature DB >> 23274919

Role of a respiratory viral panel in the clinical management of pediatric inpatients.

Grant S Schulert1, Zengqi Lu, Tammy Wingo, Yi-Wei Tang, Benjamin R Saville, Paul D Hain.   

Abstract

BACKGROUND: Respiratory viral panels (RVPs) able to detect multiple pathogens are increasingly used in the management of pediatric inpatients. Despite this, few studies have examined whether the results of these tests are associated with clinically significant changes in medical management.
METHODS: In this retrospective cohort study, we identified pediatric inpatients between August 2009 and December 2010 for whom an RVP was ordered within 24 hours of admission to a large, tertiary-care children's hospital. We used linear regression to determine whether RVP was associated with length of stay (LOS), duration of antibiotics and the number of diagnostic microbiology tests ordered, adjusting for potential confounders.
RESULTS: We found that the association between results of the RVP and LOS was dependent on a patient's admission service, specifically admission to the hematology/oncology service. We also found that patients with a positive RVP had a shorter duration of intravenous antibiotic administration (P = 0.03; 42% reduction in the geometric mean), but that this was influenced by the primary admission service. We also found that positive results of the RVP were associated with decreased LOS and shorter duration of antibiotics in patients with some common respiratory diagnoses.
CONCLUSIONS: This study lacked sufficient evidence to claim an association between a positive RVP and LOS in pediatric patients, adjusting for their underlying diagnosis. However, we found that a positive RVP was associated with a shorter duration of intravenous antibiotic administration in certain groups of patients and those with some common respiratory diagnoses. These findings help clarify the utility of rapid viral testing in the management of hospitalized pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23274919     DOI: 10.1097/INF.0b013e318284b146

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Utilization of viral molecular diagnostics among children hospitalized with community acquired pneumonia.

Authors:  Grant S Schulert; Paul D Hain; Derek J Williams
Journal:  Hosp Pediatr       Date:  2014-11

2.  Controlling testing volume for respiratory viruses using machine learning and text mining.

Authors:  Mark V Mai; Michael Krauthammer
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

3.  Impact of Respiratory Viral Panel Polymerase Chain Reaction Assay Turnaround Time on Length of Stay and Antibiotic Use in Patients With Respiratory Viral Illnesses.

Authors:  Sebastian Choi; Rubiya Kabir; Pranisha Gautam-Goyal; Prashant Malhotra
Journal:  Hosp Pharm       Date:  2017-10-10

4.  Clinical Evaluation of the Luminex NxTAG Respiratory Pathogen Panel.

Authors:  Yi-Wei Tang; Sarah Gonsalves; Janet Y Sun; Jeffrey Stiles; Kathleen A Gilhuley; Albina Mikhlina; Sherry A Dunbar; N Esther Babady; Hongwei Zhang
Journal:  J Clin Microbiol       Date:  2016-04-27       Impact factor: 5.948

5.  Noninterruptive Clinical Decision Support Decreases Ordering of Respiratory Viral Panels during Influenza Season.

Authors:  Cameron Escovedo; Douglas Bell; Eric Cheng; Omai Garner; Alyssa Ziman; Sitaram Vangala; Prabhu Gounder; Carlos Lerner
Journal:  Appl Clin Inform       Date:  2020-04-29       Impact factor: 2.342

6.  Parallel Validation of Three Molecular Devices for Simultaneous Detection and Identification of Influenza A and B and Respiratory Syncytial Viruses.

Authors:  Lifen Ling; Samuel E Kaplan; Juan C Lopez; Jeffrey Stiles; Xuedong Lu; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

7.  Do I Need Proof of the Culprit? Decreasing Respiratory Viral Testing in Critically Ill Patients.

Authors:  Katherine Innis; Denise Hasson; Lauren Bodilly; William Sveen; Erika L Stalets; Maya Dewan
Journal:  Hosp Pediatr       Date:  2020-12-15

8.  Association of respiratory viruses with outcomes of severe childhood pneumonia in Botswana.

Authors:  Matthew S Kelly; Marek Smieja; Kathy Luinstra; Kathleen E Wirth; David M Goldfarb; Andrew P Steenhoff; Tonya Arscott-Mills; Coleen K Cunningham; Sefelani Boiditswe; Warona Sethomo; Samir S Shah; Rodney Finalle; Kristen A Feemster
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

9.  Impact of a Transition from Respiratory Virus Shell Vial to Multiplex PCR on Clinical Outcomes and Cost in Hospitalized Children.

Authors:  Pui-Ying Iroh Tam; Lei Zhang; Zohara Cohen
Journal:  Children (Basel)       Date:  2017-01-07

10.  Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use.

Authors:  Denise Andrews; Yumela Chetty; Ben S Cooper; Manjinder Virk; Stephen K Glass; Andrew Letters; Philip A Kelly; Malur Sudhanva; Dakshika Jeyaratnam
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.